C18 CERAMIDE manufacturers
- N-Stearoylsphingosine
-
- $30.00 / 1mg
-
2026-04-14
- CAS:2304-81-6
- Min. Order:
- Purity: 99.89%
- Supply Ability: 10g
- Ceramide NS
-
- $0.00 / 1kg
-
2026-03-26
- CAS:
- Min. Order: 0.10000000149011612kg
- Purity: ≥95%
- Supply Ability: 20000kgs
|
| | C18 CERAMIDE Basic information |
| | C18 CERAMIDE Chemical Properties |
| Melting point | 99-101 °C | | alpha | [α]D20 -2～-5゜ (c=0.5, CHCl3) | | Boiling point | 630.97°C (rough estimate) | | density | 0.9512 (rough estimate) | | refractive index | 1.6630 (estimate) | | storage temp. | −20°C | | solubility | Chloroform (Slightly, Heated, Sonicated), Methanol (Sparingly) | | form | White to off-white powder. | | pka | 13.54±0.20(Predicted) | | color | White to Off-White | | BRN | 1717539 | | Stability: | Stable, but may be heat sensitive - store below 4 ℃. Incompatible with strong oxidizing agents. | | Cosmetics Ingredients Functions | SKIN CONDITIONING - MISCELLANEOUS
HAIR CONDITIONING | | Cosmetic Ingredient Review (CIR) | C18 CERAMIDE (2304-81-6) | | InChIKey | VODZWWMEJITOND-NXCSZAMKSA-N | | SMILES | C(N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCCCC)(=O)CCCCCCCCCCCCCCCCC |
| Safety Statements | 24/25 | | WGK Germany | 3 | | HS Code | 29225000 | | Storage Class | 11 - Combustible Solids |
| Provider | Language |
|
ACROS
| English |
| | C18 CERAMIDE Usage And Synthesis |
| Chemical Properties | Off White Powder | | Uses | The sphingolipid ceramide is a potent inhibitor of the mitochondrial permeability transition pore. | | Definition | ChEBI: N-octadecanoylsphingosine is a N-acylsphingosine in which the ceramide N-acyl group is specified as octadecanoyl (stearoyl). It has a role as a mouse metabolite. It is a N-acylsphingosine and a N-stearoyl-sphingoid base. It is functionally related to an octadecanoic acid. | | Biological Activity | C18 Ceramide based derivatives are present in low levels during neurodegeneration. It favors endoplasmic reticulum based stress and autophagy in glioma cells. Low levels of C18-ceramide are implicated in human head and neck squamous cell carcinoma. C18 ceramide may inhibit tumor progression. | | in vivo | In the rat Kainate injury model, C18-Ceramide has an increasing content in the brain after injury. C18-Ceramide might facilitate the exocytosis of glutamate from damaged neurons, thus propagating neuronal injury[1].
|
| | C18 CERAMIDE Preparation Products And Raw materials |
|